The Beauty Investor Diligence Tool
Most beauty due diligence stops at the financials. This one doesn't.
This two-part investor framework covers 11 categories of operational and regulatory risk — with specific questions and the stakes attached to each — plus a forward-looking intelligence layer on where the next wave of exposure is forming in beauty and personal care. Written for investors and advisors, not founders. Read it before the conversation begins.
Send Me The Brief
Enter your email to receive the brief. Free. No spam.
We respect your privacy. Unsubscribe at any time.
Who am I?
Melory Johnson is a beauty industry veteran with 25+ years of experience across product development, regulatory compliance, manufacturing, and commercialization. Pretty Equity is her advisory and publishing platform — translating that experience into tools, research, and insight for investors and founders navigating beauty execution risk.
What will you learn?
- How to evaluate a brand's regulatory, manufacturing, and documentation infrastructure — before capital is committed
- What contract manufacturer risk looks like from an investor's seat, including how a CM's compliance record becomes the brand's exposure
- Which forward-looking market signals — MoCRA enforcement, clinical validation, tariff exposure, leadership dependency — should change how you weight your diligence questions today
© 2020 All rights reserved